Literature DB >> 29556140

Assessment of the Monitor Unit Objective tool for VMAT in the Eclipse treatment planning system.

Sara Jiménez-Puertas1, David Sánchez-Artuñedo2, Marcelino Hermida-López2.   

Abstract

AIM: This work aims to achieve the highest possible monitor units (MU) reduction using the MU Objective tool included in the Eclipse treatment planning system, while preserving the plan quality.
BACKGROUND: The treatment planning system Eclipse (Varian Medical Systems, Palo Alto, CA) includes a control mechanism for the number of monitor units of volumetric modulated arc therapy (VMAT) plans, named the MU Objective tool.
MATERIAL AND METHODS: Forty prostate plans, 20 gynecological plans and 20 head and neck plans designed with VMAT were retrospectively studied. Each plan (base plan) was optimized without using the MU Objective tool, and it was re-optimized with different values of the Maximum MU (MaxMU) parameter of the MU Objective tool. MU differences were analyzed with a paired samples t-test and changes in plan quality were assessed with a set of parameters for OARs and PTVs.
RESULTS: The average relative MU difference [Formula: see text] considering all treatment sites, was the highest when MaxMU = 400 (-4.2%, p < 0.001). For prostate plans, the lowest [Formula: see text] was obtained (-3.7%, p < 0.001). For head and neck plans [Formula: see text] was -7.3% (p < 0.001) and for gynecological plans [Formula: see text] was 7.0% (p = 0.002). Although similar MU reductions were observed for both sites, for some gynecological plans maximum differences were greater than 10%. All the assessed parameters for PTVs and OARs sparing showed average differences below 2%.
CONCLUSION: For the three studied clinical sites, establishing MaxMU = 400 led to the optimum MU reduction, maintaining the original dose distribution and dosimetric parameters practically unaltered.

Entities:  

Keywords:  Eclipse; Monitor units; RapidArc; VMAT

Year:  2018        PMID: 29556140      PMCID: PMC5856680          DOI: 10.1016/j.rpor.2018.02.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  8 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

3.  Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.

Authors:  Dirk Wolff; Florian Stieler; Grit Welzel; Friedlieb Lorenz; Yasser Abo-Madyan; Sabine Mai; Carsten Herskind; Martin Polednik; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Radiother Oncol       Date:  2009-09-16       Impact factor: 6.280

4.  Assessment of monitor unit limiting strategy using volumetric modulated arc therapy for cancer of hypopharynx.

Authors:  Shabbir Ahamed; Navin Singh; Deleep Gudipudi; Suneetha Mulinti; Anil Talluri; Bhudevi Soubhagya; Madhusudhana Sresty
Journal:  Phys Med       Date:  2017-02-20       Impact factor: 2.685

5.  The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.

Authors:  Stephen F Kry; Mohammad Salehpour; David S Followill; Marilyn Stovall; Deborah A Kuban; R Allen White; Isaac I Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

Review 6.  Intensity-modulated radiation therapy, protons, and the risk of second cancers.

Authors:  Eric J Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

7.  Monitor unit optimization in RapidArc plans for prostate cancer.

Authors:  Stefania Clemente; Mariella Cozzolino; Costanza Chiumento; Alba Fiorentino; Rocchina Caivano; Vincenzo Fusco
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

8.  Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients.

Authors:  Bao-Tian Huang; Zhu Lin; Pei-Xian Lin; Jia-Yang Lu; Chuang-Zhen Chen
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

  8 in total
  4 in total

1.  Performance of the eclipse monitor unit objective tool utilizing volumetric modulated arc therapy for rectal cancer.

Authors:  Alejandro Prado; Ángel Gaitán; Mario Leonor; Marta Manzano; Eduardo Cabello; Raúl Díaz; Alejandro Ferrando; Ana Milanés; Gustavo Pozo
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-25

2.  Software simulation of tumour motion dose effects during flattened and unflattened ITV-based VMAT lung SBRT.

Authors:  Marta Adamczyk; Marta Kruszyna-Mochalska; Anna Rucińska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2020-06-11

3.  Limiting treatment plan complexity by applying a novel commercial tool.

Authors:  Alessandro Scaggion; Marco Fusella; Giancarmelo Agnello; Andrea Bettinelli; Nicola Pivato; Antonella Roggio; Marco A Rossato; Matteo Sepulcri; Marta Paiusco
Journal:  J Appl Clin Med Phys       Date:  2020-05-21       Impact factor: 2.102

4.  On the reduction of aperture complexity in kidney SABR.

Authors:  Mathieu Gaudreault; Keith Offer; Tomas Kron; Shankar Siva; Nicholas Hardcastle
Journal:  J Appl Clin Med Phys       Date:  2021-03-23       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.